Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Asian J Anesthesiol ; 56(2): 56-63, 2018 06.
Article in English | MEDLINE | ID: mdl-30286559

ABSTRACT

Dexmedetomidine, an α-2 adrenergic receptor agonist, provides analgesia, sedation, anxiolysis, sympatholysis and anesthetic-sparing effect, without inducing significant respiratory depression. Due to these properties, its clinical use is no longer limited to serving as a sedative agent in the intensive care unit. Proper airway management and the avoidance of cardiac and respiratory complications are common goals of everyday anesthesia practice. Ensuring airway safety is pivotal during the anesthesia stages of induction, maintenance and recovery. In this review, we focus on the advantages of dexmedetomidine in awake fiberoptic intubation (AFOI), diagnostic examinations and surgeries of patients with obstructed airways, and reducing emergence delirium effectively without causing further adverse events. With increasing implementation in different anesthetic scenarios, dexmedetomidine provides a favorable option to enhance patient safety and comfort.


Subject(s)
Adrenergic alpha-2 Receptor Agonists/pharmacology , Airway Obstruction/surgery , Dexmedetomidine/pharmacology , Delirium/prevention & control , Dexmedetomidine/adverse effects , Dexmedetomidine/pharmacokinetics , Fiber Optic Technology , Humans , Patient Safety , Perioperative Care
SELECTION OF CITATIONS
SEARCH DETAIL
...